This leads to a high TMB development in these cancers, which also acquire increased levels of mutations in several other genes associated with gastric cancer, such as in receptor tyrosine kinase pathways and the WNT/APC/β-catenin pathway. This evidence concerns the gene NTRK1 and gastric cancer.